Tendencias actuales del uso de las estatinas en dislipidemias y otros efectos extralipídicos
Fleitas Estévez, Andrés Samuel.
Rev. cuba. angiol. cir. vasc
; 18(2): 178-191, jul.-dic. 2017.
Artigo em Espanhol | LILACS, CUMED | ID: biblio-844817
Documentos relacionados
Screening for Lipid Disorders in Children and Adolescents: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
ESRD-induced dyslipidemia-Should management of lipid disorders differ in dialysis patients?
Dyslipidemia is associated with sarcopenia of the elderly: a meta-analysis.
Short-term safety and efficacy of escalating doses of atorvastatin for dyslipidemia in children with predialysis chronic kidney disease stage 2-5.
Management of Hypercholesterolemia in Pregnant Women with Atherosclerotic Cardiovascular Disease.
Short-Term Effect of Nutraceutical Fruit Juices on Lipid Metabolism in Patients with Acquired Hypercholesterolemia.
Cardiometabolic factors and risk of non-arteritic anterior ischemic optic neuropathy: a systematic review and meta-analysis.
Dyslipidemia.
Dyslipidemia in Pediatric Patients: A Cross-Sectional Study.
Inflammation compared to low-density lipoprotein cholesterol: two different causes of atherosclerotic cardiovascular disease.